HLA genotyping: indications and limits

• Published in: Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 1998-02, Vol.5 (1), p.6
• Main Authors: Tongio, M M, Dormoy, A
• Format: Article
• Language: fre
• Subjects: Alleles; Chromosome Mapping; Genotype; Histocompatibility Antigens Class I - genetics; Histocompatibility Antigens Class II - genetics; Humans; Polymerase Chain Reaction - methods; Polymorphism, Genetic
• ISSN: 1246-7820
• DOI: 10.1016/S1246-7820(98)80106-7

The polymorphism of the class I (HLA-A, B, C) and class II (HLA-DR, DQ, DP) antigens was for a long time investigated using serological methods. Today molecular biology methods are available to define the numerous HLA alleles by genotyping [(82 HLA-A alleles, 174 HLA-B, 38 HLA-C, 166 HLA-DRB1, 27 HLA-DQB1, 71 HLA-DPB1) (nomenclature 1996)]. Many different molecular biology methods can be used to define these alleles (PCR- RFLP, PCR-SSOP, PCR-SSP, PCR-SBT), the choice of method depends on the number of genotypes achieved per day and the time required to obtain a result. The resolution degree of results can reach two levels: low resolution: provides results almost identical to those obtained by serological methods. Low resolution is sufficient to find HLA-identical siblings for bone marrow transplantation, to type organ donor-recipient pairs and for diagnosis in most HLA disease associations; high resolution: defines HLA allele subtypes. High resolution is essential to type bone marrow donor-recipient pairs when the donor is unrelated. Molecular biology methods will gradually replace serological methods in the future. The only restriction is that some alleles, defined at the genomic level, are not expressed at the cell surface and are thus not functional.